Categories: News

Marriott International Announces Termination of Agreement with Sonder

BETHESDA, Md., Nov. 9, 2025 /PRNewswire/ — Marriott International, Inc. (NASDAQ: MAR) today announced that its licensing agreement with Sonder Holdings Inc. (NASDAQ: SOND, “Sonder”) is no longer in effect due to Sonder’s default. As a result, Sonder is no longer affiliated with Marriott Bonvoy, and Sonder properties are not available for new bookings on Marriott’s channels.

- Advertisement -

Marriott’s immediate priority is supporting guests currently staying at Sonder properties and those with upcoming reservations. Marriott will be contacting guests who booked directly through Marriott channels, including marriott.com, the Marriott Bonvoy App and Marriott’s worldwide reservation centers, to address their reservation and booking needs.  Guests who booked through a third-party online travel agency should contact those organizations. Marriott remains committed to minimizing disruption to guests’ travel plans.

- Advertisement -

Guests with questions about current or future reservations at a Sonder property booked through Marriott channels can contact Marriott customer service here.

- Advertisement -

ABOUT MARRIOTT INTERNATIONAL
Marriott International, Inc. (Nasdaq: MAR) is based in Bethesda, Maryland, USA, and encompasses a portfolio of over 9,700 properties across more than 30 leading brands in 143 countries and territories, as of September 30, 2025. Marriott operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties all around the world. The company offers Marriott Bonvoy®, its highly awarded travel platform. For more information, please visit our website at www.marriott.com, and for the latest company news, visit www.marriottnewscenter.com. In addition, connect with us on Facebook and @MarriottIntl on X and Instagram.

- Advertisement -

NOTE ON FORWARD-LOOKING STATEMENTS
This press release contains “forward-looking statements” within the meaning of United States federal securities laws, including statements related to Marriott International, Inc.’s plans and expectations following the termination of its licensing agreement with Sonder Holdings Inc.; Marriott’s plans to support impacted guests and minimize disruption to travel plans; and similar statements concerning anticipated future actions and expectations that are not historical facts. We caution you that these statements are not guarantees of future performance and are subject to numerous evolving risks and uncertainties that we may not be able to accurately predict or assess, including the risk factors identified in our U.S. Securities and Exchange Commission filings, including our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q. Any of these factors could cause actual results to differ materially from the expectations we express or imply in this press release. We make these forward-looking statements as of the date of this press release and undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. 

- Advertisement -

MEDIA CONTACT
Maggie McNerney
Director, Media Relations
Marriott International
Maggie.McNerney@Marriott.com

- Advertisement -

IRPR#1

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/marriott-international-announces-termination-of-agreement-with-sonder-302609515.html

- Advertisement -

Recent Posts

Pluristyx and Solesis Launch First-of-its-Kind PluriForm-GFP-3D Transfection Kit, Solving Critical Bottlenecks in Suspension Culture Transfection

New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection…

3 hours ago

BioCryst to Report Fourth Quarter 2025 Financial Results on February 26

February 05, 2026 07:01 ET  | Source: BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Feb.…

3 hours ago

Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

February 05, 2026 07:00 ET  | Source: Dianthus Therapeutics, Inc. NEW YORK and WALTHAM, Mass.,…

3 hours ago

Microchip Technology Receives Frost & Sullivan’s 2025 Global Product Leadership Recognition for Automotive Touchscreen Controllers

Microchip is recognized for advancing automotive HMI innovation with flexible, safety-compliant touchscreen controller technology that…

3 hours ago

International Fleet Review 2026 to Showcase India’s Naval Diplomacy and Maritime Partnerships

The Indian Navy is set to host the International Fleet Review 2026 (IFR) at VisakhapatnamVISAKHAPATNAM,…

3 hours ago

Phaos Technology Holdings (Cayman) Limited Provides Response to Unusual Market Action

SINGAPORE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS),…

4 hours ago